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Abstract
Background: Various CACNA1A missense mutations cause familial hemiplegic migraine type 1 (FHM1), a rare monogenic
subtype of migraine with aura. FHM1 mutation R192Q is associated with pure hemiplegic migraine, whereas the S218L
mutation causes hemiplegic migraine, cerebellar ataxia, seizures, and mild head trauma-induced brain edema. Transgenic
knock-in (KI) migraine mouse models were generated that carried either the FHM1 R192Q or the S218L mutation and
were shown to exhibit increased CaV2.1 channel activity. Here we investigated their cerebellar and caudal cortical
transcriptome.
Methods: Caudal cortical and cerebellar RNA expression profiles from mutant and wild-type mice were studied using
microarrays. Respective brain regions were selected based on their relevance to migraine aura and ataxia. Relevant
expression changes were further investigated at RNA and protein level by quantitative polymerase chain reaction (qPCR)
and/or immunohistochemistry, respectively.
Results: Expression differences in the cerebellum were most pronounced in S218L mice. Particularly, tyrosine hydro-
xylase, a marker of delayed cerebellar maturation, appeared strongly upregulated in S218L cerebella. In contrast, only
minimal expression differences were observed in the caudal cortex of either mutant mice strain.
Conclusion: Despite pronounced consequences of migraine gene mutations at the neurobiological level, changes in cortical
RNA expression in FHM1 migraine mice compared to wild-type are modest. In contrast, pronounced RNA expression
changes are seen in the cerebellum of S218L mice and may explain their cerebellar ataxia phenotype.
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Introduction
Familial hemiplegic migraine (FHM) is a rare
Mendelian subtype of migraine with aura that is char-
acterized by transient hemiparesis during the aura
phase (1). FHM type 1 (FHM1) is caused by specific
missense mutations in the CACNA1A gene that
encodes the pore-forming a1 subunit of voltage-gated
CaV2.1 calcium channels, which are involved in the
regulation of neurotransmitter release (2). CACNA1A
is expressed throughout the central nervous system, but
expression is particularly high in the cerebellum (3).
The clinical phenotype with FHM1 mutations can
range from pure hemiplegic migraine (e.g. with
mutation R192Q (4)) to a severe complex phenotype of
hemiplegic migraine with cerebellar ataxia, seizures,
and mild head trauma-induced cerebral edema that
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can result in fatal coma in the case of mutation S218L
(5,6).
To investigate the neurobiological consequences of
FHM1 mutations, we generated transgenic knock-in
(KI) mouse models in which we introduced the
FHM1 R192Q or the S218L mutation in the mouse
Cacna1a gene by a gene-targeting approach (7,8). At
the neurobiological level, both KI mutants show an
increased neuronal calcium influx and neurotransmitter
release. In addition, both KI mutants revealed an
increased susceptibility to cortical spreading depression
(CSD), a wave of neuronal and glial cell depolarization
that originates in the occipital cortex and slowly propa-
gates over the brain cortex and is considered the cause
of the migraine aura (9). These neurobiological conse-
quences are more pronounced in S218L mice. In line
with the more complex phenotype seen in S218L
patients, only S218L KI mice exhibit cerebellar ataxia
and an increased susceptibility to seizures and mild
head trauma-induced edema (5,6,8). For the present
study we wanted to know whether neurobiological dif-
ferences and cerebellar ataxia can be explained by
changes at the RNA level. To this end we focused our
RNA expression profiling to two brain regions: the
caudal part of the cortex containing the occipital
cortex and the cerebellum. The caudal cortex was
chosen because it is the brain region where CSD
waves start. The cerebellum was investigated because
this brain region is involved in ataxia. We hypothesized
that expression differences under basal conditions
might highlight (molecular) mechanisms related to
migraine aura (reflected in the caudal cortical profiles)
or ataxia (reflected in the cerebellar profiles). Whereas
cortical RNA expression profiles were shown to be
remarkably similar between genotypes, specific differ-
ences in gene expression in the cerebellum could be
linked to ataxia-relevant mechanisms.
Materials and methods
Animals
Transgenic KI mice carrying either the human FHM1
R192Q or S218L mutation were generated by gene tar-
geting of the Cacna1a gene. In these mice the neomycin
selection cassette was removed by in vivo deletion by
crossing KI mice with Cre deleter mice (7,8). Seven- to
10-week-old homozygous KI and wild-type mice of
both genders were used. KI mice were generated in a
mixed C57Bl/6J and 129J/Ola background and were
backcrossed with C57BL/6J for several generations so
the remaining percentage of 129J/Ola background is
below 5%. KI mice were backcrossed with C57BL/6J
for five (R192Q) and for three (S218L) generations.
Each group consisted of six independent biological
replicates, unless mentioned otherwise (see Table 1).
For the immunohistochemistry experiments of tyrosine
hydroxylase (Th), biologically independent animals
were used. For the quantitative polymerase chain reac-
tion (qPCR) replication experiments a biologically
independent set of four animals per group was used,
which were backcrossed with C57BL/6J for 10 gener-
ations. Confirmatory genotyping was performed by
PCR analysis on genomic DNA from tail biopsies as
described before (7,8). Animal care and procedures
were approved by the local ethical committee according
to national guidelines.
Dissections of brain structures
Animals were sacrificed by cervical dislocation and
brains were rapidly removed from the skull. Brain
material was dissected and snap-frozen in liquid nitro-
gen within 15minutes and stored at 80C until RNA
isolation. Brain material was dissected in nine parts: the
cerebellum (in two halves), both hemispheres of the
cortex (with each hemisphere further dissected in
three equal parts; the most caudal part containing the
occipital cortex), and the brainstem.
RNA isolation
The right half of the cerebellum and the most caudal
third of the right cortex were chosen for expression
profiling. For total RNA isolation, the Machery
Nagel RNA isolation kit (Du¨ren, Germany) was used
in combination with an Ultra-turrax T25 Polytron
(Janke & Kunkel, Staufen, Germany) mechanical hom-
ogenizer. In brief, frozen tissue was crushed using a
mortar under liquid nitrogen. Subsequently, tissue
was homogenized in lysis buffer using the Polytron.
Total RNA was bound to silica membrane of
Macherey Nagel columns, while contaminating DNA
Table 1. Experimental groups of mice.
Genotype Brain structure Gender (n)
Wild-type mice Cerebellum Male (6)
Female (6)
Caudal cortex Male (6)
Female (6)
S218L knock-in mice Cerebellum Male (6)
Female (5)
Caudal cortex Male (6)
Female (5)
R192Q knock-in mice Cerebellum Male (6)
Caudal cortex Male (6)
The numbers in parentheses indicate the number of independent bio-
logical replicates that were included per experimental group.
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was removed by rDNase. At the end of the procedure,
total RNA was eluted with RNase-free water. RNA
integrity was determined using the Agilent 2100
Bioanalyzer total RNA nanochips (Agilent, Foster
City, CA, USA). All RNA samples that were included
in the study had a minimal RNA integrity number
(RIN) value of 7.0.
Gene expression profiling using Illumina
microarrays
Biotin-labeled cRNA was produced using a linear amp-
lification kit (IL1791; Ambion, Austin, TX, USA) using
300 ng of total RNA as input. cRNA samples were
hybridized on Illumina mouse-6 Bead Chips, which
contain 44,505 probes. Chip hybridizations, washing,
Cy3-streptavidin (Amersham Biosciences, Uppsala,
Sweden) staining, and scanning were performed on an
Illumina Bead Station 500 platform (San Diego, http://
www.illumina.com) using reagents and protocols sup-
plied by the manufacturer.
Gene expression profile data analysis
Resulting data files were loaded into Rosetta Resolver
version 7.2 (Rosetta Biosoftware, Seattle, WA, USA).
Raw data were normalized using the standard Rosetta
error model for Illumina arrays. Differences in gene
expression between groups were evaluated using an
error-weighted two-way analysis of variance
(ANOVA) with genotype and gender as factors and
Benjamini-Hochberg FDR was used for multiple test-
ing corrections (FDR, p< 0.05). Post-hoc analysis was
performed using Tukey-Kramer (FDR, p< 0.05).
Caudal cortex and cerebellum profiles were analyzed
separately. A ‘‘cortical signature’’ representing genes
that are differently expressed in the caudal cortex of
both mutant mice was selected based on ANOVA stat-
istics and post-hoc analysis. Genes with a significant
ANOVA p value for the parameter genotype, and
that based on the post-hoc analysis were differently
expressed between mutant mice (both S218L and
R192Q strains) and wild-type mice, were selected.
Similarly, an ‘‘ataxia signature’’ was created that rep-
resents genes that were differently expressed in the cere-
bellum of S218L but not of R192Q mice.
Using DAVID (http://david.abcc.ncifcrf.gov/
home.jsp) (10), function labels from the PANTHER
Classification System were ascribed to each gene.
Genes were grouped into categories according to
these function labels to determine enrichment of certain
categories, and corrected for multiple testing using
Benjamini-Hochberg FDR. These enrichment analyses
were performed only on gene sets containing at least
100 genes.
Literature-based relationships
Literature-based relationships between genes in the spe-
cific gene sets and migraine were studied using the Anni
text-mining program (Anni version 2.1) (11). For each
gene or disorder a concept profile was generated by the
program. A concept profile is a summary of all con-
cepts directly co-mentioned with the disease or gene
concept (i.e. the main concept) in PubMed abstracts.
The strength of association for each concept with the
main concept is calculated using 2 2 contingency
tables and the uncertainty coefficient. The association
between two concept profiles is calculated using vector-
based matching (e.g. inner product score) over the con-
cepts that the two profiles have in common.
Quantitative real-time-PCR
Biologically independent RNA samples were used for
evaluation of microarray results by qPCR. Selection of
differentially expressed genes (DEGs) for validation by
qPCR was based on; 1) expression fold-changes equal
or higher than 1.3, 2) expression levels high enough to
be detectable by qPCR, and 3) the genes should repre-
sent pathways that are overrepresented in the data set
based on the gene ontology (GO) term analysis. Only
genes from the ‘‘ataxia gene signature’’ were selected, as
the GO term analysis for the ‘‘caudal cortical signa-
ture’’ did not show overrepresented pathways.
First-strand cDNA was synthesized using random
hexamer primers. Subsequently, qPCRs were per-
formed on the MyiQTM Single-Color Real-Time PCR
Detection System (Bio-Rad, Hercules, CA, USA) using
gene-specific primers (Supplemental Table 1). cDNAs
were analyzed in duplicate, after which the average
cycle threshold (Ct) was calculated per sample.
Analyzed Ct values ranged from 18 to 33, and primer
efficiencies ranged between 90% and 105%. Expression
differences between mutant and wild-type samples were
calculated using the Ct method using Gapdh as
housekeeping gene (genotype and gender showed no
effect on Gapdh expression in both caudal cortical and
cerebellar tissue). Differential expression was calculated
using Student’s t test.
Immunohistochemistry of TH
Mice were anaesthetized with Nembutal (50mg/kg,
intraperitoneally (i.p.)) and perfused intracardially
with phosphate-buffered saline (PBS) followed by 4%
paraformaldehyde in 0.1M phosphate buffer (pH 7.4).
Post-fixation was performed for two hours in 4% buf-
fered paraformaldehyde followed by overnight incuba-
tion in 10% sucrose in 0.1M phosphate buffer at 4C.
Next, tissue was embedded in 10% sucrose with 11%
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gelatin, fixed with 30% sucrose in 4% buffered paraf-
ormaldehyde for 2.5 hours at room temperature, fol-
lowed by overnight incubation in 30% sucrose in 0.1M
phosphate at 4C. Tissue was cut into 40 mm sagittal
sections and processed for free-floating immunohisto-
chemistry. Briefly, sections were incubated in 10% heat-
inactivated normal horse serum, 0.5% Triton X100 in
Tris-buffered saline (TBS) for two hours and then incu-
bated with primary rabbit anti-Th antibody (AB152,
1:2,000; Chemicon, Temecula, CA, USA), diluted in
TBS containing 1% normal horse serum, 0.4% Triton
X100 at 4C. Secondary biotin-labeled goat anti-rabbit
antibody (1:200; Vector Laboratories, Burlingame, CA,
USA) incubation was performed for two hours at room
temperature. Finally, for detection, sections were incu-
bated with the avidin-biotin kit (Vector Laboratories)
for two hours at room temperature, washed, and devel-
oped in 0.1mg/ml diaminobenzidine with 0.005%
H2O2.
Single nucleotide polymorphism (SNP) analysis
Using the Mouse Genome Informatics (MGI) database
(http://www.informatics.jax.org/), SNPs surrounding
the Cacna1a locus on mouse chromosome 8 were
selected that could distinguish C57BL/6 J- and 129/
Ola-derived sequences. Using genomic tail DNA, SNP
genotypes for all mutant mice that were included in the
study were determined by standard PCR combined
with direct sequencing.
Results
Here we studied RNA expression profiles of the cere-
bellar and the caudal part of the cortex containing the
occipital cortex of two Cacna1a KI mouse models of
migraine. As the mutations in our KI mouse models
change the amino acid sequence of the pore-forming
a1 subunit of CaV2.1 channels, we inspected RNA pro-
files of the genes coding for CaV subunits to see whether
major compensations had occurred at the RNA level.
No major changes in RNA levels of CaV auxiliary sub-
units (i.e. b1-4, g1-8, and a2d1-3), except for minor
differences in Cacnb1, Cacnb3, and in Cacng7 in the
caudal cortex and cerebellum of S218L mice were
observed (Supplementary Table 2). In addition, we
observed a downregulation of Cacna1a (fold-change –
1.29; p¼ 0.02) in the cerebellum of R192Q mice and an
upregulation of Cacna1h (fold-change 1.41; p¼ 0.004)
in the cerebellum of S218L mice (Table 2).
To statistically evaluate differences in gene expres-
sion profiles between Cacna1a KI and wild-type mice, a
two-way ANOVA was performed for cerebellum and
caudal cortex separately, with genotype and gender as
factors. The effect of gender on gene expression was
minimal; only a few genes were significantly differen-
tially expressed between males and females in both
structures. When comparing the expression profiles
for the different genotypes (i.e. wild-type, S218L, and
R192Q), we noticed that both for the cerebellum and
caudal cortex a large portion of significant DEGs is
located on chromosome 8 (in the caudal cortex: 64%
and 87%, and in the cerebellum 41% and 19%, for
R192Q and S218L, respectively). Chromosome 8 con-
tains the Cacna1a gene that was modified by gene tar-
geting. Although KI mice were backcrossed with
C57BL/6 J for several generations, the region directly
flanking the mutated Cacna1a gene remained of 129/
Ola genetic background. The ‘‘chromosome 8 genes’’
are likely differently expressed because of genetic back-
ground differences (12) although some may be in fact
because of the presence of the FHM1 mutation. We
determined the genomic boundaries of 129-derived
chromosome 8 regions in the FHM1 mice and could
show that the 129/Ola-derived region flanking the
Cacna1a gene extended maximally 37Mb upstream to
46Mb downstream of the R192Q mutation and 37Mb
upstream and 52Mb downstream of the S218L muta-
tion. As the 129/Ola-derived region involved a rather
large part of chromosome 8 in some of the mice, we
decided to exclude all genes located on chromosome 8
from the gene signatures used for subsequent analyses.
No such enrichment of DEGs was found for other
chromosomal loci, indicating that the expression differ-
ences for genes not located on chromosome 8 do not
result from remaining 129/Ola genetic background
regions. For the caudal cortex few DEGs remained
Table 2. Expression levels of genes encoding pore-forming
subunits of CaV channels.
Gene
Cerebellum Caudal cortex
R192Q S218L R192Q S218L
Cacna1a 1.29 (0.02)a 1.13 (0.19) 1.24 (0.06) 1.11 (0.37)
Cacna1b 1.06 (0.27) 1.01 (0.90) 1.08 (0.28) 1.00 (0.97)
Cacna1c 1.13 (0.08) 1.04 (0.60) 1.04 (0.62) 1.08 (0.38)
Cacna1d 1.05 (0.67) 1.21 (0.09) 1.04 (0.86) 1.01 (0.94)
Cacna1e 1.01 (0.96) 1.11 (0.50) 1.12 (0.52) 1.03 (0.85)
Cacna1f 1.06 (0.62) 1.03 (0.76) 1.08 (0.56) 1.06 (0.71)
Cacna1g 1.05 (0.57) 1.08 (0.27) 1.03 (0.93) 1.12 (0.69)
Cacna1h 1.02 (0.84) 1.42 (0.004)a 1.03 (0.74) 1.07 (0.48)
Cacna1i 1.02 (0.80) 1.01 (0.81) 1.07 (0.36) 1.01 (0.82)
Cacna1s 1.18 (0.09) 1.06 (0.52) 1.09 (0.36) 1.03 (0.82)
Output generated with a two-way analysis of variance (ANOVA) with
genotype and sex as factors. Numbers represent the mean fold-change
for each gene transcript seen in the respective mutant mice compared to
wild-type mice; p value for this fold-change is indicated in parentheses.
aFold-change with a p< 0.05.
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after exclusion of chromosome 8 genes (i.e. 22 for
R192Q KI and 10 for S218L KI) (Supplementary
Tables 3 and 4). For the cerebellum, the number of
DEGs that remained after chromosome 8 gene exclu-
sion was considerably higher: 82 for R192Q KI and 335
for S218L KI mice (Supplementary Tables 5 and 6).
Because the caudal cortex is most relevant for the
observed increased susceptibility to CSD in KI mice, we
selected a ‘‘cortical gene signature’’ by selecting genes
that were differentially expressed in the caudal cortex of
both mutant mouse models (Figure 1(a)). Nine genes
were differentially expressed in both strains of mutant
mice (Table 3); all showed modest fold-changes
(between –1.6 and 1.5). Six genes (i.e. Lsm10, Gpr34,
Gpr23, Ctxn3, Gli3, and Tnnc1) were upregulated in
both strains, whereas Cort was upregulated in one
and downregulated in the other. Camkk1 and Tom1l2
were downregulated in both strains.
For the cerebellum, we extracted an ‘‘ataxia gene
signature’’ containing genes that were differentially
expressed in the cerebellum of S218L KI mice (when
compared to R192Q KI and wild-type mice). The
‘‘ataxia gene signature’’ contained 296 genes (Figure
1(b)). Using bioinformatic resource DAVID, a GO
term and pathway analysis was performed to identify
enrichment of functional GO categories. This resulted
in significant over-representation of three biological
process GO terms, two molecular function GO terms,
and one pathway (Table 4). Several were related to
signal transduction and neurotransmitter synthesis.
Subsequently, qPCR analyses were performed for five
DEGs from these pathways in biologically independent
samples that were backcrossed for seven additional
generations to better assess that the identified gene
expression differences are indeed due to effects related
to mutated calcium channels. The results confirmed the
findings of the microarray experiments (Figure 2).
Using the Anni text-mining program we investigated
possible literature-based relationships between the
term ataxia and the genes in the ‘‘ataxia gene signa-
ture.’’ The Ppp2r2b gene, encoding brain-specific regu-
latory subunit of the protein phosphatase PP2A, and
the Gfap gene, encoding glial fibrillary acidic protein,
showed most obvious literature-based relationships
with ataxia. Notably, mutations in these genes cause
spinal cerebellar ataxia type 12 (SCA12) (13) and
Alexander disease (14), which can involve ataxia as a
symptom. Ppp2r2b and Gfap were both upregulated in
the cerebellum of the S218L KI mice with a fold-change
of 1.2 (p¼ 6.4 104) and 1.6 (p¼ 2.9 104), respect-
ively. The most striking fold-change in the ‘‘ataxia gene
signature,’’ however, was observed for tyrosine





(S218L vs wild type)
Fold-change
(R192Q vs wild type)
Camkk1 Calcium/calmodulin-dependent
protein kinase kinase 1, alpha
3.80 106 1.06 (0.05) 1.29 (4.04 1016)
Cort Cortistatin 0.01 1.17 (0.02) 1.19 (3.1 103)
Ctxn3 Cortexin 3 8.33 103 1.25 (2.1 104) 1.35 (2.20 108)
Gli3 GLI-Kruppel family member GLI3 0.03 1.16 (2.4 103) 1.28 (2.1 104)
Gpr23 G protein-coupled receptor 23 0.04 1.26 (1.1 103) 1.38 (5.51 106)
Gpr34 G protein-coupled receptor 34 6.08 108 1.34 (5.5 1010) 1.43 (9.44 1012)
Lsm10 U7 snRNP-specific Sm-like protein 0.03 1.12 (9.0 104) 1.16 (4.80 104)
Tnnc1 Troponin C, cardiac/slow skeletal 0.03 1.19 (0.04) 1.45 (4.0 105)
Tom1l2 Target of myb1-like 2 (chicken) 2.53 103 1.47 (2.0 105) 1.53 (1.33 107)
ANOVA: analysis of variance. Genes from chromosome 8 were excluded. Numbers represent the mean fold-change for each gene transcript seen in
the respective mutant mice compared wild-type mice. The numbers in parentheses represent the p value for the respective fold-change.
(a) Occipital Cortex (b) Cerebellum
296 39 431 9 13
S218L Kl R192Q Kl S218L Kl R192Q Kl
Figure 1. (a). Differentially expressed genes in the caudal
cortex of mutant knock-in (KI) mice. Only nine genes are dif-
ferentially expressed in the caudal cortex of both KI mouse
models (‘‘cortical gene signature’’). (b) Differentially expressed
genes in cerebellum. No less than 296 genes are differentially
expressed in the cerebellum of S218L KI mice compared to
R192Q KI and wild-type mice (‘‘ataxia gene signature’’).
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hydroxylase (Th) (fold-change 13.1; p¼ 3.92 1020).
Th upregulation was confirmed at the protein level as
evidenced by the strong immunoreactivity in Purkinje
cells of S218L mice (Figure 3).
Discussion
Here we performed the first gene-expression profiling
study in transgenic KI mouse models with human
Table 4. Pathways that are significantly overrepresented in the ‘‘ataxia’’ gene signature (p< 0.05 after Benjamini-Hochberg
correction for multiple testing).
GO term p value Genes
BP: Other amino acid
metabolism
6.3 104 Acy3, Ddc, Gad2, Hdc, Shmt1, Tph2, Th
BP: Amino acid metabolism 3.9 103 Arhgef3, Agmat, Acy3, Ddc, Fah, Gad2, Hdc, Qdpr, Shmt1, Slc6a7, Slc7a3, Tph2, Th
BP: Signal transduction 1.3 102 Adcyap1, Adora2b, Angpt2, Arhgef3, Blnk, Bmp1, Cabp2, Camk1d, Camk2a, Casq2, Cck,
Ccl3, Ccl4, Ccl9, Cd63, Cib2, Col16a1, Col17a1, Col6a1, Coro1a, Crlf1, Crtam, Ddr1,
Dtx4, Fcgr1, Fxyd6, Gja1, Gjb1, Glra2, Grb2, Gng4, Gpr34, Grb7, Hhtl, Inpp1, Irak2, Jun,
Lamc2, Lrrn1, Lrrtm4, Marcks, Mmd2, Mslnl, Npy, Ntng2, Nyx, Olfml2b, Opn3, Pdcl,
Plcb3, Plxnb3, Ppm1e, Rasl11b, Rassf3, Relb, Rgs2, Rhob, Rhod, Rorc, Rxfp3, S100a1,
Sdk1, Sema4a, Sla, Spata13, Spsb4, Sst, Tac1, Tgfb1, Th, Tlr2, Tlr7, Tph2, Triobp,
Tspan11, Tspan17, Vtn, Zfyve9
MF: Signaling molecule 5.3 103 Adcyap1, Angpt2, Bcl2a1b, Blnk, Ccl3, Ccl4, Ccl9, Cck, Cd63, Crlf1, Elmo2, Gm12791,
Lgals3, Marcks, Npy, Plcb3, Plxnb3, Spp1, Sema4a, Sla, Slamf9, Sst, Tac1, Tspan11,
Tspan17, Tgfb1
MF: Extracellular matrix 7.2 103 6530402F18Rik, Col4a6, Col6a1, Col16a1, Col17a1, Emilin2, Hapln2, Lamc2, Lrrn1,
Lrrtm4, Mmp17, Mslnl, Nyx, Spp1, Tlr2, Tlr7
Pathway: 5-Hydroxytryptamine
biosynthesis
8.7 103 Ddc, Hdc, Tph2, Th
Output generated using DAVID. Genes in bold were selected for validation by quantitative polymerase chain reaction (qPCR).
























Figure 2. Quantitative PCR analysis of genes altered in the cerebellum of S218L mice. Data are derived from a set of biologically
independent samples, and are expressed as fold changes (means SD), normalized to Gapdh mRNA expression, where the values for
wild-type mice were set at 1.00. *p< 0.05 compared to the wild-type mice.
PCR: polymerase chain reaction; SD: standard deviation.
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FHM1 mutations R192Q and S218L to investigate
whether the mutations lead to expression differences
in migraine-related mouse brain tissues. We investi-
gated the caudal part of the cortex that included the
visual cortex because CSD, the electrophysiological
substrate of the migraine aura, originates in this area
of the cortex (9,15). We also studied the cerebellum
because cerebellar ataxia originates from this area of
the brain and cerebellar ataxia is a prominent part of
the migraine-associated phenotype of S218L mice.
In line with earlier studies on these mouse models
that revealed comparable numbers of functional CaV2.1
channels at the plasma membrane without up- or
downregulation of other CaV channel types (7,8),
mRNA expression levels of the mutated Cacna1a gene
and genes encoding other subunits of CaV channels did
not show major alterations of CaV subunits as a mech-
anism for the compensation of the gain-of-function of
CaV2.1 channels. Consequently, we postulate that the
clinical features seen in mice and patients with FHM1
gene mutations are more likely the result of changed
functionality of CaV2.1 channels, perhaps in combin-
ation with changes in downstream targets of these
channels.
As both KI mutants were generated on a mixed
C57BL/6J 129/Ola genetic background (7,8), despite
being back-crossed to C57BL/6J for several gener-
ations, gene sequences on chromosome 8 directly flank-
ing the mutated Cacna1a gene are still of 129/Ola
origin. Valor and Grant have shown that remnant
129/Ola sequences may lead to subtle gene-expression
differences in transgenic mouse models because of
mixed genetic differences surrounding the gene that
was modified during the transgenesis process (12).
When comparing expression profiles from our mutant
KI and wild-type mice, we indeed observed an over-
representation of DEGs located in close proximity to
the mutated Cacna1a gene. It is unlikely that all these
DEGs are the direct result of the introduced FHM1
mutation. We postulate that the presence of a small
number of nucleotides that were introduced during
the targeting procedure might as well have exerted a
cis-effect on gene expression of some of the neighboring
genes on chromosome 8. For this reason, we decided to
exclude chromosome 8 genes from further analyses.
Previous molecular and electrophysiological studies
have shown that neuronal excitability and cortical glu-
tamate release is increased in the KI mutants (7,8,16).
Here, we could show that the increased neuronal excit-
ability is not accompanied by prominent gene expres-
sion changes in the caudal cortex (at least under
unchallenged conditions). Only nine genes were differ-
entially expressed in the cortex of mutant KI mice;
Camkk1, Cort, Ctxn3, Gli3, Gpr23, Gpr34, Lsm10,
Tnnc1, and Tom1l2. Differential expression of cortical
Camkk1, Gpr34, Tom1l2, and Cort gives an indication
for an immune-related component, as these genes seem
involved in the immune response (17–21).
In contrast to the limited amount of nonchromo-
some 8 genes differentially expressed in the cortex, a
total of 378 genes were differentially expressed in the
cerebellum of the mutant KI mice, of which 296 specif-
ically in the cerebellum of S218L mice that exhibit cere-
bellar ataxia (all not located on chromosome 8). GO
Figure 3. Protein expression of tyrosine hydroxylase (Th) in the cerebellum. Immunohistochemistry using Th-specific antibody
(brown signal). Some Purkinje cells stain positive in the S218L mutant. Left panel: wild-type, right panel: S218L. M: molecular layer;
PC: Purkinje cell layer; G: Granule cell layer; WM: white matter.
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term analysis with the S218L-specific ‘‘ataxia gene sig-
nature’’ showed significant overrepresentation of genes
belonging to pathways related to neurotransmitter syn-
thesis and intracellular signaling. Especially genes
related to the synthesis of the neurotransmitter sero-
tonin were differentially expressed (Table 4).
In the S218L-specific ‘‘ataxia’’ gene signature, the
largest fold-change was observed for the Th gene that
encodes the rate-limiting enzyme of the biosynthetic
pathway of catecholamines, dopamine, norepinephrine,
and epinephrine (22). Th overexpression was confirmed
at the protein level with immunohistochemistry
(Figure 3). Th is transiently expressed in the cerebellum
during development, but is absent (or very low
expressed) in the cerebellum of adult mice (23).
Hence, Th expression in the adult Purkinje cells is con-
sidered a marker for delayed maturation of the cerebel-
lum. Interestingly, other ataxic mouse models with
naturally occurring Cacna1a mutations (i.e. Rolling
Nagoya, Tottering, and Leaner) also show a high, per-
sistent Th expression in adult cerebellum (24).
However, as phosphorylation of several serine residues
was shown to be absent in upregulated Th in these
mice, but important for Th activity (25), it is unclear
whether Th function is abnormal in Cacna1a mutant
mice. Notably, an expression profiling study in
Purkinje cell degeneration mice, which are characterized
by degeneration of cerebellar Purkinje cells and pro-
gressive ataxia, showed a two-fold increase in expres-
sion of the Th gene (26).
Several genes in the S218L-specific ‘‘ataxia’’ gene
signature can be linked to cerebellar ataxia relevant
pathways. For example, 5’ noncoding CAG expansions
in the PPP2R2B gene, which encodes a brain-specific
regulatory subunit of the protein phosphatase PP2A
holoenzyme, cause SCA12 (13). The repeat expansion
results in an increased PPP2R2B expression (27),
similar to what was observed in the cerebellum of the
S218L KI mice. Gain-of-function mutations in glial
fibrillary acidic protein (GFAP) are associated with
infantile and juvenile Alexander disease, a rare leuko-
dystrophy of the cerebellum (14), with gait ataxia as a
clinical feature in many patients with adult-onset
Alexander disease (28). Transgenic mice in which
wild-type human GFAP was overexpressed were pre-
sented as a mouse model for Alexander disease (29).
Overexpression of Gfap was also observed in the
‘‘ataxia gene signature’’ in the cerebellum of S218L
mice.
Previous studies showed increased neuronal calcium
influx and neurotransmitter release in FHM1 KI mice.
Here we show that these neurobiological consequences
of migraine gene mutations are not accompanied by
prominent RNA expression differences in the cortex
of these migraine mouse models. These neurobiological
consequences could perhaps be linked to, for instance,
post-transcriptional and/or epigenetic mechanisms, or
expression changes that become pronounced only after
a trigger, which would be in line with the episodic
nature of migraine. Future studies need to show
whether expression profiles in other brain regions or
after a trigger, like CSD induction, will show expression
changes between migraine mice and wild-type mice.
Another important message from this study is that
gene-expression studies in transgenic animals may
result in identification of multiple DEGs on the tar-
geted chromosome resulting from background strain
differences instead of being due to the introduced muta-
tion. This should be taken into account when interpret-
ing the gene-expression profiles derived from the
targeted chromosome. Clear differences in RNA
expression profiles were observed in the cerebellum of
S218L KI mice that may reflect the chronic ataxic
phenotype in this strain of mice.
Clinical implications
. Gene-expression data from familial hemiplegic migraine type 1 (FHM1) knock-in mice can be used to study
neurobiological consequences of CACNA1A mutations.
. The R192Q CACNA1A gene mutation does not lead to profound gene-expression changes.
. The S218L CACNA1A gene mutation is associated with pronounced gene-expression changes in the cere-
bellum that might explain the cerebellar ataxia part of the phenotype.
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